📊 BAK Key Takeaways
Is Braskem S.A. (BAK) a Good Investment?
Insufficient financial data available for fundamental analysis. With 1 metric available and no income statement, balance sheet, or cash flow data accessible through SEC EDGAR, a meaningful assessment of Braskem SA's financial health, profitability, or operational trends cannot be performed.
Braskem's fundamentals remain pressured by structurally weak petrochemical spreads, heavy debt, and recurring non-operating hits, which drove a large 2024 net loss despite revenue and gross profit recovery. Liquidity is still adequate, but cash generation is inconsistent and free cash flow stayed negative after capex, leaving the balance sheet vulnerable if the industry downcycle or legal cash outflows persist. Recent 2025 quarters show some operational recovery, but not enough to offset leverage, FX sensitivity, and event-driven liabilities.
Why Buy Braskem S.A. Stock? BAK Key Strengths
- Unable to assess - data unavailable
- Unable to assess - data unavailable
- Unable to assess - data unavailable
- Revenue and gross profit improved materially in 2024, showing operating leverage when spreads and volumes recover
- Liquidity is still meaningful, with sizable cash, positive working capital, and historically long-dated debt maturities
- Mexico operations and higher value-added sales mix provide some path to margin stabilization
BAK Stock Risks: Braskem S.A. Investment Risks
- Complete lack of current income statement data prevents profitability analysis
- No balance sheet metrics available to evaluate financial leverage or solvency
- Absence of cash flow data prevents assessment of operational efficiency and capital allocation
- Very high leverage and large foreign-currency debt exposure make earnings and credit quality highly sensitive to FX moves
- Profitability is volatile, with weak recurring EBITDA relative to the debt burden and negative free cash flow after investment spending
- Alagoas-related provisions, restructuring charges, and other non-recurring items continue to pressure cash flow and reported earnings
Key Metrics to Watch
- Revenue and net income trends when data becomes available
- Operating cash flow and free cash flow quality
- Debt-to-equity ratio and interest coverage for financial stability
- Recurring EBITDA relative to interest expense and total debt service
- Operating cash flow/free cash flow and cash outflows tied to Alagoas and restructuring
Braskem S.A. (BAK) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BAK Profit Margin, ROE & Profitability Analysis
BAK vs Materials Sector: How Braskem S.A. Compares
How Braskem S.A. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Braskem S.A. Stock Overvalued? BAK Valuation Analysis 2026
Based on fundamental analysis, Braskem S.A. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Braskem S.A. Balance Sheet: BAK Debt, Cash & Liquidity
BAK Revenue Growth, EPS Growth & YoY Performance
BAK SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Braskem S.A. (CIK: 0001071438)
❓ Frequently Asked Questions about BAK
What is the AI rating for BAK?
Braskem S.A. (BAK) has a Combined AI Rating of SELL from Claude (HOLD) and ChatGPT (SELL) with 44% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are BAK's key strengths?
Claude: Unable to assess - data unavailable. Unable to assess - data unavailable. ChatGPT: Revenue and gross profit improved materially in 2024, showing operating leverage when spreads and volumes recover. Liquidity is still meaningful, with sizable cash, positive working capital, and historically long-dated debt maturities.
What are the risks of investing in BAK?
Claude: Complete lack of current income statement data prevents profitability analysis. No balance sheet metrics available to evaluate financial leverage or solvency. ChatGPT: Very high leverage and large foreign-currency debt exposure make earnings and credit quality highly sensitive to FX moves. Profitability is volatile, with weak recurring EBITDA relative to the debt burden and negative free cash flow after investment spending.
What is BAK's revenue and growth?
Braskem S.A. reported revenue of N/A.
Does BAK pay dividends?
Braskem S.A. does not currently pay dividends.
Where can I find BAK SEC filings?
Official SEC filings for Braskem S.A. (CIK: 0001071438) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BAK's EPS?
Braskem S.A. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is BAK a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Braskem S.A. has a SELL rating with 44% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is BAK stock overvalued or undervalued?
Valuation metrics for BAK: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy BAK stock in 2026?
Our dual AI analysis gives Braskem S.A. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is BAK's free cash flow?
Braskem S.A.'s operating cash flow is N/A, with capital expenditures of N/A.
How does BAK compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio N/A (avg: 1.6).